| ID | Study | Sample Size | Grade | Country | Dosage | Design |
Outcome
Indicators |
| Authors-Year | Duration/Frequency/Weeks | ||||||
| 1 | (Acar and Arslan 2023) | 23 | S | Turkey | 40 min/2 times/10 weeks | NR | CT, SK |
| 2 | (Şişman et al. 2023) | 34 | S | Turkey | 80 min/1 time/8 weeks | NR | MC |
| 3 | (Akbayir and Tedikçi 2022) | 38 | S | Turkey | 120 min/1 time/8 weeks | NR | MA |
| 4 | (Işıklar and Öztürk 2022) | 40 | L | Turkey | 40 min/2 times/10 weeks | NR | CT, PS |
| 5 | (Wu 2021) | 173 | S | China | 40 min/2 times/4 weeks | R | CT |
| 6 | (Zulkifli and Hashim 2020) | 61 | S | Malaysia | —/—/11 sessions | NR | CT |
| 7 | (Khanmohammadi et al. 2020) | 44 | S | Iran | —/1 time/12 weeks | NR | LO, PM |
| 8 | (Mehnehj et al. 2020) | 50 | S | Iran | 60 min/2 time/6 weeks | NR | RS |
| 9 | (Ventista 2019) | 738 | L | UK | 30 min/1 time/40 weeks | NR | CT, C |
| 10 | (Abbasi et al. 2017) | 50 | L | Iran | —/—/12 weeks | NR | CT |
| 11 | (Tian and Liao 2016) | 62 | S | China | 100 min/1 time/10 weeks | NR | RC |
| 12 | (Youssef et al. 2016) | 246 | S | Australia | —/—/24 weeks | NR | RC |
| 13 | (Erfani and Rezaei 2016) | 40 | S | Iran | 120 min/1 time/12 weeks | NR | CT |
| 14 | (Fair et al. 2015b) | 275 | S | USA | 60 min/1 time/22–26, 4–10 weeks | R | CA |
| 15 | (Fair et al. 2015a) | 183 | S | USA | 60 min/1 time/22–26 weeks | R | CA |
| 16 | (Tok and Mazl 2015) | 74 | L | Turkey | 120 min/2 time/10 weeks | NR | RC, LC |
| 17 | (Pourtaghi et al. 2014) | 32 | S | Iran | 75 min/12 weeks | NR | C |
| 18 | (Lam 2012) | 28 | S | China | 90 min/2 times/16 weeks | R | RS |
| 19 | (Marashi 2008) | 60 | S | Iran | 70 min/11 sessions | NR | RS |
| 20 | (Topping and Trickey 2007a) | 115 | L | UK | 60 min/1 time/58 weeks | NR | CA |
| 21 | (Topping and Trickey 2007b) | 177 | L | UK | 60 min/1 time/58 weeks | NR | CA |
| 22 | (Othman and Hashim 2006) | 45 | S | Malaysia | —/—/16 weeks | NR | RS, RC |
| 23 | (Jo 2000) | 54 | L | South Korea | 30 min/4 times/24 weeks | NR | CM |
| 24 | (Sprod 1998) | 54 | S | UK | 70 min/1 time/40 weeks | NR | RS |
| 25 | (Pálsson 1995) | 126 | L | Iceland | 80 min/1 time/24 weeks | NR | RS |
| 26 | (Chamberlain 1993) | 160 | L | USA | 60 min/5 times/12 weeks | NR | RS, HC |
| 27 | (Slade 1989) | 50 | S | Australia | 120 min/12 sessions | NR | RS |
| 28 | (Jenkins 1986) | 60 | S | UK | 45 min/about 20 weeks | NR | RS |
| 29 | (Martin and Weinstein 1985) | 964 | L, S | USA | —/—/about 32 weeks | PP | CT |
| 30 | (Iorio et al. 1984) | 336 | L | USA | 45 min/2 times/40 weeks | PP | CT |
| 31 | (Yeazell 1982) | 100 | L | USA | 45 min/1 time/32 weeks | NR | RC |
| 32 | (Cinquino 1981) | 47 | L | USA | 120 min/1 time/28 weeks | PP | RS, C |
| 33 | (Cummings 1979) | 29 | L | USA | 40 min/2 times/7.5weeks | NR | LT |